7 studies found for:    DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3
Show Display Options
Rank Status Study
1 Completed Januvia Re-examination Study (MK-0431-181 AM3)
Condition: Diabetes Mellitus Non-insulin-dependent
Intervention: Drug: Sitagliptin
2 Completed Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: AC2993;   Drug: Placebo
3 Completed Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: AC2993;   Drug: Placebo
4 Completed
Has Results
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: rosiglitazone-metformin fixed dose combination;   Drug: metformin + glimepiride
5 Completed
Has Results
Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)(COMPLETED)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: sitagliptin phosphate;   Behavioral: Comparator: Diet;   Behavioral: Comparator: Physical Activity
6 Completed
Has Results
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: insulin glargine (HOE901);   Drug: omega-3 polyunsaturated fatty acids (PUFA);   Drug: placebo;   Device: reusable pen device for insulin injection
7 Recruiting PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Hypertriglyceridemia
Interventions: Drug: Metformin Eicosapentaenoate;   Drug: Metformin HCl and Vascepa

Indicates status has not been verified in more than two years